Background: Significant alterations in autonomic nervous system (ANS) function, vasomotor reactivity, and cerebral blood flow may develop from damage to brain ANS regulatory areas in heart failure (HF). This preferentially right-sided injury occurs largely in autonomic structures perfused by the middle cerebral artery. Indications of altered, asymmetrical perfusion raise the potential for further neural damage.
H eart failure (HF) is accompanied by loss of tissue and other indications of neural injury in specific brain sites, primarily on the right side (Woo, Macey, Fonarow, Hamilton, & Harper, 2003) , with the damage especially affecting structures that regulate autonomic action. Those sites include the right insular and ventral medial prefrontal cortices, as well as the hypothalamus and hippocampus-all areas with significant autonomic modulation roles (Kumar et al., 2011; Woo et al., 2005) . The consequences of asymmetric autonomic regulatory injury are severe, because lateralized sympathetic outflow establishes circumstances that can lead to exaggerated outflow and arrhythmia (Schwartz, Periti, & Malliani, 1975) . The underlying pathological processes leading to the lateralized brain injury are unknown but may develop from impaired cerebral blood flow (CBF) to affected areas or inability of the vasculature to respond to transient regional needs, that is, impaired vasomotor reactivity, particularly during autonomic nervous system (ANS) challenges (Gruhn et al., 2001; Woo et al., 2003) .
Global CBF, the volume of blood flow delivered to the head over 1 minute, is reduced by approximately 30% in subjects with severe HF (Gruhn et al., 2001) . Reduced CBF is associated with vasomotor reactivity deficits, defined as the ability of cerebral vessels to adequately dilate or constrict to changes in CO 2 levels in blood and surrounding tissue (Franklin, 2002) .
More extensive dysfunctional vasomotor reactivity correlates with worsening HF (Blaber et al., 1997; Georgiadis et al., 2000; Xie et al., 2005) and is markedly reduced in patients with ANS dysfunction and HF (Blaber et al., 1997; Georgiadis et al., 2000) . Reduced global CBF and altered vasomotor reactivity place HF patients at risk for cerebral ischemia and stroke. Although altered global CBF appears in HF, it is unclear whether such declines are uniform or vary by brain region; asymmetric CBF reductions would help explain the laterality and localization of injury in the syndrome.
In the same cohort of HF patients, autonomic areas were preferentially injured on the right side of the brain, including the insular and ventral-frontal cortices (Woo et al., 2003) , as well as cingulate, amygdala, and hippocampal areas, to which the insula projects. All of these areas serve essential autonomic functions, as does the cerebellum, which is injured in HF. The right insular cortex helps determine the magnitude of sympathetic outflow (Cechetto & Chen, 1990 ), and the ventral medial frontal cortex plays essential sympathetic modulatory roles (King, Menon, Hachinski, & Cechetto, 1999) . Cerebellar areas are necessary for dampening extremes of blood pressure change (Lutherer, Lutherer, Dormer, Janssen, & Barnes, 1983) . Earlier studies showed that all of these areas exhibit both structural injury and impaired functional responses to autonomic challenges (Kumar et al., 2011; Ogren et al., 2012) . The structures and vessels of interest are illustrated in multiple views in Netter (1983) and include Section I, Plate 1 (insula); Section II, Plate 5 (cingulate, amygdala, hippocampus); Section II, Plates 4, 6 (middle cerebral artery); Section II, Plate 10 (cerebellum); Section VIII, Plate 51, (hypothalamus); and Section III, Plate 6 (ventral frontal cortex). The cerebellum also responds markedly to CO 2 administration and modifies cardiovascular responses to vestibular-mediated orthostatic challenges, which are typically affected in HF. All of these structures are preferentially damaged on the right side of the brain in HF, an outcome potentially dependent on impaired perfusion on that side. That possibility needs to be confirmed with an examination of bilateral responsiveness to autonomic challenges.
The objective was to determine if regional vasomotor reactivity and cerebral blood flow velocity (CBFV) changes appear in HF subjects which could reflect and, perhaps, underlie the brain injury and impaired function detected earlier by structural and functional magnetic resonance imaging procedures (Woo et al., 2003 . Succinctly, CBFV differs from CBF in that the former measures the speed with which blood travels through the cerebral vessels (cm/s) whereas the latter measures the overall volume (ml/min); vasomotor reactivity indicates the ability of blood vessels to dilate or constrict in response to changing levels of CO 2 . These indices interact in that flow velocity (CBFV) will change depending on the volume of flow through the vessel (CBF) and/or the diameter of the vessel (vasomotor reactivity).
Altered vasomotor reactivity in an HF patient has serious clinical implications. With the reduced CBF, altered cerebral autoregulation, and autonomic dysfunction found in the condition, everyday activities that instigate autonomic challenges (lifting, straining, etc.) place the HF patient at risk of reduced cerebral perfusion repeatedly through normal activities of daily living. Autonomic challenges, such as a Valsalva maneuver (or behaviors similar to such challenges), reduce mean arterial blood pressure and, to a greater extent, CBF (Dawson, Panerai, & Potter, 1999) , leaving HF patients vulnerable to hypoperfusion, ischemia, and stroke.
Because significant injury appeared in the cerebellar and right insular cortices and cerebellar deep nuclei, challenges mediated by these structures were used, which would elicit changes in CBF. Thus, a CO 2 challenge was used, which elicits substantial vasodilation to assess vascular reactivity and hyperventilation to rapidly reduce CO 2 ; a Valsalva maneuver (forced expiratory effort to raise vascular pressure); and an orthostatic challenge of head tilt, which is mediated heavily by cerebellar structures (via vestibular mechanisms). Cerebral blood flow velocity and vasomotor reactivity were recorded with noninvasive portable transcranial Doppler from the middle cerebral arteries bilaterally, because they supply several more-rostral structures serving autonomic regulation, including the insular cortices (Netter, 1983) . The specific aims were to:
1. examine the responses of both 5% CO 2 inhalation and hyperventilation to alter CO 2 , and assess vasomotor reactivity (Ringelstein, Sievers, Ecker, Schneider, & Otis, 1988) ; 2. determine the response and laterality of CBFV and vasomotor reactivity integrity during Valsalva maneuvers; and 3. evaluate vascular responses to an orthostatic challenge that can alter CBFV and indicate ANS dysfunction in HF subjects (Bradley & Davis, 2003) . All three challenges, including CO 2 manipulation, Valsalva maneuvers, and orthostatic manipulation, may influence CBFV in the middle cerebral arteries, with alterations potentially outlining the basis for laterality and potential for injury to structures supplied by those vessels.
METHODS

Subjects
Heart failure patients with reduced left ventricular ejection fraction (n = 40, New York Heart Association Class II-III) were recruited via flyers in the Ahmanson-University of California at Los Angeles Cardiomyopathy Clinic, and healthy control subjects (n = 42) were found via flyers placed in the University of California at Los Angeles Medical Center and various campus locations. Demographics for all subjects are summarized in Table 1 . Thirty-eight HF patients were on beta-blockers, 22 were on angiotensin-converting enzyme (ACE) inhibitors, 13 were taking angiotensin receptor blockers, and 23 were receiving statins. Etiology of HF was ischemic in 12 (30%) and nonischemic in 28 (70%). All HF patients had systolic HF with left ventricular ejection fraction of 0.40 or less. Implantable cardioverter-defibrillators were present in 29/40 (72%) of the HF patients. Control subjects denied use of vasoactive or psychotropic medications, previous neural injury, cardiac problems, or psychological diagnosis. No HF or control subjects had a history of trauma, stroke, or migraine headache. Subjects were advised to abstain from alcohol, tobacco, or caffeine 24 hours before the study and were excluded from participation if any of these substances were used within that window. Power analysis of CBFV and vasomotor reactivity measures indicated that a total sample size of 38 (19 subjects per group) would detect a large effect size (0.8) on F tests for independent samples and a large effect size (Cohen's w = 0.5) on a chi-square at an alpha of 0.05 and power of 0.80 (Faul, Erdfelder, Lang, & Buchner, 2007) . The study oversampled by 21 HF and 23 control subjects.
The study complies with the Declaration of Helsinki, and the University of California at Los Angeles Institutional Review Board approved the data collection protocol and study. Subjects provided informed consent.
Data Collection Protocol
Transcranial Doppler All subjects were asked to lie in a supine position on a gurney, with the head of the gurney flat and a rolled sheet placed underneath the subject's head. The gurney head was raised only as needed for HF patients to ensure unlabored breathing; no HF patient required the head raised greater than 20°. Prior to study onset, bilateral extracranial internal carotid artery Doppler insonation of all subjects revealed no carotid artery stenosis. The study sequence was outlined to the subjects, after which the transcranial Doppler apparatus was attached. All subjects followed a proscribed sequence for the ANS examinations, with a timed rest period between tests. CO 2 Following a 2-minute baseline period, subjects breathed a mixture of 5% CO 2 and 95% O 2 for 3 minutes (Ringelstein et al., 1988) . Following a 2-minute recovery, subjects performed a 1-minute voluntary hyperventilation consisting of rapid forceful efforts to lower CO 2 . Recorded measures of CBFV in HF and control subjects included baseline values, maximum values during the CO 2 inhalation phase, minimum values during the hyperventilation phase, and the value differences between CO 2 and hyperventilation phases.
Valsalva Maneuver All subjects performed four 18-second Valsalva trials during CBFV evaluation. A 58-second resting period was provided between each trial for CBFV baseline recovery, a time sufficient to restore baseline values (Dawson et al., 1999) . Because CBFV is lowest at end-expiration (Phase II) of the Valsalva maneuver, the end-expiratory period was chosen to measure responses. The CBFV values at end-exhalation for all accepted challenges for each subject were averaged and included in the analysis.
Orthostatic Changes Subjects lay supine on a gurney for 3 minutes, sat upright (with investigator assistance when necessary) on the edge of the gurney for 3 minutes, and stood by the gurney for the final 3 minutes. All subjects shifted from supine to sitting and from sitting to standing within a 15-second period. Recorded CBFV measurements in HF and control subjects included baseline (supine) and minimum values upon sitting and standing.
Instruments and Tests
Transcranial Doppler Cerebral blood flow velocity was evaluated via transcranial Doppler during all ANS challenges. Simultaneous bilateral middle cerebral artery blood flow velocities were measured with a Nicolet Companion III transcranial Doppler recorder (Viasys Healthcare, Madison, WI) with 2-MHz probes on a high-profile transducer attachment system. Internal carotid artery blood flow and middle cerebral artery flow velocity during systemic changes in blood pressure are strongly correlated using transcranial Doppler, providing a basis for validity of the measure (Newell, Aaslid, Lam, Mayberg, & Winn, 1994) . CO 2 Expired CO 2 was measured via an open mouthpiece with a side-port sampling system (Capstar-100, C.W.E., Inc., Ardmore, PA). Nose clips were placed to avoid nasal CO 2 leakage. All subjects underwent a CO 2 challenge that included CO 2 inhalation and hyperventilation phases and was conducted by an investigator with extensive experience with transcranial Doppler recordings.
Valsalva Maneuver Subjects exhaled forcefully into a restricted tube leading to a pressure transducer to monitor airway load pressure. A visual stimulus system consisting of separate lights was used to alert subjects when to exhale and when minimum load pressure was achieved. One light indicated when to begin and end exhalation, whereas another light was illuminated as long as load pressure was maintained greater than the requisite Vasomotor Reactivity The percentage difference between the middle cerebral artery mean CBFV peak during the CO 2 inhalation and trough during hyperventilation phases was calculated to yield the subject's vasomotor reactivity (Ringelstein et al., 1988; Ringelstein, Grosse, Matentzoglu, & Glöckner, 1986 ). Subjects were categorized as "normal" if vasomotor reactivity was in the range of 68%-110% or "abnormal" if outside that range (either <68% or >110%; Ringelstein et al., 1986) .
Statistical Analysis
Data analyses were performed using Statistical Package for the Social Sciences (SPSS, v. 15.0, Chicago, IL) and included independent samples t tests and Fisher's (F) tests to compare bilateral CBFV and raw vasomotor reactivity values between the HF and control subjects. Chi-square and independent samples t tests were used for subject demographic data analyses. To evaluate differences of magnitude of laterality within groups, Wilcoxon signed-rank tests were used. Abnormality in the HF group relative to the control group was assessed using chi-square tests for independence, with vasomotor reactivity values categorized as "normal" or "abnormal," as defined above. We were unable to insonate right and left middle cerebral arteries in all subjects, resulting in nonnormally distributed samples; hence, a nonparametric test, the Wilcoxon signed-rank (i.e., paired) test, was used to assess laterality.
RESULTS
On average, HF participants were approximately 4 years older than those in the control group (Table 1) . The proportion of men in the HF group did not significantly differ from that in the control group. Among HF patients, mean (SD) left ventricular ejection fraction was 26.8% (8.3%), and 72% (29/40) had implantable cardioverter defibrillators.
Between-Group Differences CO 2 Challenge Bilateral middle cerebral artery CBFV values for all subjects during the three phases of the CO 2 challenge and differences between the CO 2 and hyperventilation phases are shown in Figure 1 . Bilateral CBFV reductions were associated with HF versus control subjects at all phases (t test for independent samples, p < .05 for baseline, CO 2 inhalation, hyperventilation, and CO 2 inhalation-hyperventilation), with all but the left-sided hyperventilation phase reaching statistical significance (t test for independent samples, p < .05).
Valsalva Maneuver
Bilateral CBFV values for HF and control subjects during the Valsalva maneuver are shown in Figure 2 . Significant bilateral differences between HF and control subjects in CBFV were noted at baseline and during the Valsalva maneuver (t test for independent samples, all p < .05). Bilateral CBFV values in HF patients were below those of control subjects, even at baseline.
Orthostatic Changes Bilateral CBFV values for the HF and control subjects for different positions during orthostatic challenge are shown in Figure 3 . Bilateral reductions of CBFV in HF versus control subjects were noted during all three phases (baseline, sitting, and standing); however, differences at baseline were significant only on the right and differences sitting were significant only on the left (t test for independent samples, p < .05).
Laterality
CO 2 Challenge Right versus left CBFV values for the three phases of the CO 2 challenge and differences between the CO 2 and hyperventilation phases were compared within the HF and control subjects and are shown in Figure 4 . Significant rightsided reductions at baseline, during CO 2 inhalation, and during hyperventilation were associated with the HF patients (all p < .05, Wilcoxon). No significant differences appeared between left and right CBFV values in control subjects.
Valsalva Maneuver Right and left CBFV values in HF and
control subjects are shown in Figure 5 ; no significant laterality differences were noted in either HF or control subjects.
Orthostatic Changes Bilateral CBFV values of the two groups are shown in Figure 6 . Significant right-sided reduction of flow appeared at baseline in HF patients ( p < .05, Wilcoxon). No significant laterality differences were noted in the control subjects.
Vasomotor Reactivity
Raw and categorized vasomotor reactivity values for all subjects are shown in Table 2 . Same-side comparisons of vasomotor reactivity revealed greater frequency of abnormalities in patients with HF than in control subjects (p = .00001). Results from the control subjects and HF patients, categorized as hyperreactive, normal, and hyporeactive, are shown in Table 3 . The proportion of vasomotor reactivity values falling outside the normal range was two to three times higher in HF patients (right side: p = .04, df = 37; left side: p = .004, df = 34; chi-square tests for independence). The greatest difference was found with respect to hyporeactivity, with right-sided hyporeactivity appearing in 11 HF patients but no controls. Left-sided hyporeactivity was noted in 12 HF patients versus one control.
DISCUSSION
Middle cerebral artery CBFV values were reduced in HF relative to control subjects during CO 2 manipulation, Valsalva maneuvers, and orthostatic challenges, and these blood flow velocity differences were lateralized, with right-sided values lower than the left during the CO 2 and orthostatic challenges, but not during the Valsalva maneuver. A greater incidence of vasomotor reactivity abnormalities was associated with HF over control subjects, as indicated by inappropriate vascular responses to elevation and lowering of CO 2 ; both left-and right-sided vasomotor reactivity were adversely affected. The reduction of CBFV in HF patients, which was more pronounced on the right side, may underlie the laterality of brain tissue injury found in HF patients. Of clinical interest, the findings point to potential mechanisms underlying the tissue injury responsible for the exaggerated sympathetic drive in HF as well as potential mechanisms accompanying unilateral impaired perfusion during simple orthostatic challenges. Tissue injury appears in animal models with as little as a 25 ml/100 g/min CBF reduction (Murphy, Chen, & Lee, 2007) . Transcranial Doppler measurements of CBFV reflect changes in CBF (Wallasch & Kropp, 2012) . The velocity changes here would lead to substantially reduced flow over those values, with CBFV differing by as much as 30% in particular challenges. Because neural injury is seldom recoverable, the long-term clinical consequences are major. 
Cerebral Blood Flow Velocity
Reduced CBF in HF, as shown by others (Alves et al., 2005; Gruhn et al., 2001) , may contribute to the regional tissue damage found earlier in the syndrome (Woo et al., 2003) . We can now add that the flow deficits are lateralized; HF patients showed significantly lower right-sided middle cerebral artery CBFV at all but one time point during the ANS challenges relative to control subjects, and left-sided CBFV differed between HF and control subjects at all but two points of ANS testing. Moreover, reduced right-sided CBFV appeared during the CO 2 challenge in HF, and while supine for orthostatic testing. Such reduced CBFV is a concern, because the lower flow results in poorer perfusion and may trigger or enhance brain tissue injury, especially to autonomic areas, contributing to further deterioration in the syndrome. The three separate ANS challenges highlight the nature of CBFV deficits in HF and emphasize the laterality of the effects. The impaired CBFV responses to CO 2 reflect interference with vasodilatory processes, damage to structures that regulate chemoreception, including deep nuclei of the cerebellum (Lutherer et al., 1983) , or modify baroreflex responses, such as those mediated by the insular cortex (Cechetto & Chen, 1990) . The abnormal CBFV patterns in HF subjects during the Valsalva maneuver may have evolved from a combination of cingulate, insular, and cerebellar injuries-all structures that assist in regulation of blood pressure.
Previously described cerebellar injury may especially contribute to CBFV differences, because the cerebellum serves chemoreceptor and pulmonary mechanoreceptor regulatory roles, both of which will affect flow (Xu & Frazier, 1997) . The CO 2 and Valsalva challenges alter respiratory drive: CO 2 through chemoreceptor mechanisms and Valsalva efforts through voluntary motor action (expiratory efforts). Increased CO 2 also affects activity in the insular cortex , an additional structure damaged in HF. The insular response to CO 2 has the potential to modify hypothalamic sympathetic outflow Macey, Woo, & Harper, 2007) .
The cerebellar damage found earlier in HF (Kumar et al., 2011; Woo et al., 2003) affected areas not related to gross movement, because overt ataxia and intentional tremor were absent. The extent of cerebellar damage in HF was apparently sufficient to alter chemoreceptor action, but not so great as to affect vestibulocerebellar responses to major body position changes. The paucity of differences between HF and control subjects during orthostatic testing may result from maintained integrity of the vestibular system, which could offset the cerebellar damage during body position changes.
A portion of the CBFV reductions in the HF subjects may result from increased endothelin and tumor necrosis factor-a (Boffa et al., 2005) . Endothelin expression is enhanced in the presence of tumor necrosis factor-a, one source of which is myocardial macrophages (Torre-Amione et al., 1996) , which are elevated in HF. Elevated levels of vasoconstrictors may contribute to reduced CBFV in HF patients during portions of the CO 2 challenge. Increased levels of these two vasoconstrictors may contribute to a "ceiling effect," which limits further 
Laterality
Right-sided CBFV was lower than left-sided in all subjects at every measurement point except one, during the CO 2 inhalation phase in control subjects, although not every point reached significance. These laterality differences are notable, considering the injury found in the insular cortices, with greater right insula damage where CBFV is lowest. The etiology of the unequal flow is unclear; however, it may contribute to both insular injury and lateralization of injury found in HF.
Vasomotor Reactivity
The source of vasomotor reactivity abnormalities in HF remains unclear. Abnormal vasomotor reactivity responses in HF are of concern, because subjects with moderate to severe vasomotor reactivity reductions (hyporeactivity) show dysfunctional cerebral autoregulation (Ringelstein et al. 1988) , the ability to maintain constant CBF during fluctuations in systemic mean arterial blood pressure (Jünger et al., 1997; Kirkness, Mitchell, Burr, & Newell, 2001) . As noted earlier, more extensive dysfunctional vasomotor reactivity correlates with worsening HF (Blaber et al., 1997; Georgiadis et al., 2000; Xie et al., 2005) ; although the HF patients enrolled were all within New York Heart Association Class II-III and, therefore, did not have advanced HF, yet transcranial Doppler revealed significantly aberrant vasomotor reactivity. This finding is of concern, because many of these patients were receiving beta-blockade, ACE inhibitors, or angiotensin receptor blocker medications that reduce blood pressure, and thus, they may be at risk for cerebral ischemia when subjected to natural challenges similar to those that were imposed in these studies. Previous studies on cerebral autoregulation in HF patients report mixed findings (Ackerman, 2001; Gruhn et al., 2001) . However, the CBFV differences found here between HF and control subjects during orthostatic challenges show that cerebral autoregulation is significantly impaired.
Aberrations of vasomotor reactivity can be induced by trauma, stroke, migraine headache, or reduced CBF (Alves et al., 2005; Baumgartner & Baumgartner, 1998; Franklin, Sandström, Johansson, & Bålfors, 1997; Thie, Fuhlendorf, Spitzer, & Kunze, 1990) . No participant had a history of any of these conditions, and the vasomotor reactivity differences should not result from such processes. Among the structures injured in HF patients, the insulae, being perfused by the middle cerebral arteries, are of particular interest. The insulae send substantial projections to the hypothalamus, cingulate cortex, and other autonomic regulatory areas and are instrumental in regulation of blood pressure and heart rate; the insular injury may contribute to the dysfunctional vasomotor reactivity found in this sample. Vasomotor reactivity abnormalities in HF may also develop from decreased CBF (Alves et al., 2005; Franklin et al., 1997; Gruhn et al., 2001) . It remains unclear whether decreased CBF contributes to the structural damage or interacts with the damage to affect vasomotor reactivity status.
Limitations One study limitation was the medication regimens.
Nearly all HF patients were on beta-blockade, and a large proportion was on ACE inhibitors, angiotensin receptor blockers, or statins. These medications may have contributed to variations in CBFV between the groups. Whereas short-term treatment with beta-blockers (which lowers cardiac output) can temporarily reduce CBF, long-term therapy, now standard in HF patients, should not be problematic for CBF, as the predominant long-term effect is reduction of peripheral resistance (Bertel, Marx, & Conen, 1987; Wilbur & James, 2005) . Treatment with ACE inhibitors increases CBF and CBFV and decreases pulsatility index (Pieni ek, Dimitrow, & Jasi ski, 2001) . Statin medications modify endothelial function (Rosenson & Tangney, 1998) ; hence, one might expect fewer incidences of altered vasomotor reactivity in HF patients taking statins. Improved vasomotor reactivity appears in patients with subcortical small-vessel disease when taking Pravastatin (Sterzer et al., 2001) . In this study, statins did not appear to play a role in vasomotor reactivity normalcy within the HF group. Thus, it is somewhat unlikely that the differences found in CBFV and vasomotor reactivity resulted from medication regimens of the HF patients, although that interpretation remains speculative.
The HF patients were moderately older than the control subjects by an average of 4 years. Exclusion criteria included those who were older than 65, a limitation to minimize ANS variations occurringwith advancing age, such as autonomic neuropathy. Because HF is most common in those older than 65 (McMurray & Stewart, 2000) , CBFV and vasomotor reactivity differences between older HF and control subjects may be greater than those found here. Future studies should include closer age matching of HF to control subjects and subjects greater than 65 years old to confirm these findings. The transcranial Doppler technique poses several limitations, as well, because the procedure is limited to assessing certain arteries, is an indirect measure, and depends on the skill of the operator. A single, very experienced operator was used for all of the studies.
Conclusions
Bilateral middle cerebral artery CBFV was reduced in HF patients, relative to control subjects following CO 2 , Valsalva maneuvers, and orthostatic challenges, which recruit the ANS. Mean CBFV values in HF patients were below control subject levels at every evaluation point, except during the CO 2 challenge inhalation phase. Lateralized deficits in HF CBFV were noted during the CO 2 challenge and orthostatic testing, but not during the Valsalva maneuver. Cerebral vasomotor reactivity was also bilaterally affected in HF patients.
The ANS challenges emulated frequent actions encountered in daily life; the CO 2 challenge reflects oxygen and CO 2 changes that might appear during exercise or speaking, the Valsalva maneuver simulates straining during exertion, and orthostatic testing reflects the frequent positional changes occurring with normal daily activity. Thus, the lower CBFV values and altered responses to ANS challenges are a concern, because lower flow leads to reduced perfusion of brain tissue, exacerbating the potential for further injury during ANS-stimulating activities. Dysfunctional vasomotor reactivity can limit the ability to protect the brain in the face of systemic blood pressure alterations. Assessment of HF patients with transcranial Doppler may provide a relatively inexpensive noninvasive procedure to potentially assist identification of patients at greater risk for cerebral perfusion alterations.
